SF1 and adrenal cortex carcinoma: All three models were validated as ACC tumors based on IHC expression of the common neuroendocrine marker synaptophysin, the adrenal specific marker SF1, and the cell proliferation marker Ki67 (Supplementary Fig. 6B-D).